Susquehanna International Group’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $120K | Sell |
11,570
-890
| -7% | -$9.25K | ﹤0.01% | 5824 |
|
2025
Q1 | $164K | Buy |
+12,460
| New | +$164K | ﹤0.01% | 5628 |
|
2024
Q2 | – | Sell |
-1,505
| Closed | -$29.3K | – | 6445 |
|
2024
Q1 | $29.3K | Sell |
1,505
-3,863
| -72% | -$75.3K | ﹤0.01% | 5252 |
|
2023
Q4 | $111K | Buy |
+5,368
| New | +$111K | ﹤0.01% | 5303 |
|
2023
Q3 | – | Sell |
-1,198
| Closed | -$40.2K | – | 6234 |
|
2023
Q2 | $40.2K | Sell |
1,198
-26,838
| -96% | -$902K | ﹤0.01% | 5250 |
|
2023
Q1 | $1.17M | Buy |
28,036
+27,347
| +3,969% | +$1.14M | ﹤0.01% | 2669 |
|
2022
Q4 | $23.4K | Sell |
689
-571
| -45% | -$19.4K | ﹤0.01% | 5324 |
|
2022
Q3 | $61K | Sell |
1,260
-3,294
| -72% | -$159K | ﹤0.01% | 5448 |
|
2022
Q2 | $179K | Buy |
4,554
+3,305
| +265% | +$130K | ﹤0.01% | 4652 |
|
2022
Q1 | $46K | Sell |
1,249
-3,642
| -74% | -$134K | ﹤0.01% | 5328 |
|
2021
Q4 | $478K | Sell |
4,891
-472
| -9% | -$46.1K | ﹤0.01% | 3870 |
|
2021
Q3 | $669K | Buy |
5,363
+4,020
| +299% | +$501K | ﹤0.01% | 3304 |
|
2021
Q2 | $168K | Buy |
+1,343
| New | +$168K | ﹤0.01% | 4921 |
|
2021
Q1 | – | Sell |
-547
| Closed | -$50K | – | 5671 |
|
2020
Q4 | $50K | Buy |
547
+152
| +38% | +$13.9K | ﹤0.01% | 4618 |
|
2020
Q3 | $29K | Buy |
+395
| New | +$29K | ﹤0.01% | 4278 |
|
2020
Q2 | – | Sell |
-9,621
| Closed | -$696K | – | 4807 |
|
2020
Q1 | $696K | Buy |
+9,621
| New | +$696K | ﹤0.01% | 2479 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 4667 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 4924 |
|
2019
Q1 | – | Sell |
-423
| Closed | -$34K | – | 4266 |
|
2018
Q4 | $34K | Sell |
423
-1,508
| -78% | -$121K | ﹤0.01% | 3387 |
|
2018
Q3 | $901K | Buy |
+1,931
| New | +$901K | ﹤0.01% | 1541 |
|
2018
Q2 | – | Sell |
-672
| Closed | -$205K | – | 4516 |
|
2018
Q1 | $205K | Buy |
+672
| New | +$205K | ﹤0.01% | 2812 |
|
2017
Q2 | – | Sell |
-447
| Closed | -$192K | – | 4207 |
|
2017
Q1 | $192K | Buy |
+447
| New | +$192K | ﹤0.01% | 2840 |
|